Product description
FEMASITOL 2.0 Sachets is the new development Femasitol 2.0 contains an equal amount of myo-inositol to restore ovulation, optimize IVF procedures and prevent /manage gestational diabetes. The substitution of folic acid with 5-MTHF, the biologically active molecule, makes it possible to bypass MTHFR, and thus restart maternal-fetal metabolic processes and prevent neural tube defects, particularly in PCOS women at particular risk of folate deficiency. (Food for Special Medical Purposes, “FSMP”)
 
Indications
Significantly reduce the incidence of gestational diabetes 
Beneficial not only for women with PCOS but also for those with risk factors including including a history of T2D
The mechanism of action during gestational diabetes includes improving insulin signaling but also action on fatty acid synthesis
As with PCOS, FEMASITOL is more relevant than metformin, which has no drug marketing approval in this indication and is less well tolerated
 
Unique selling points (USP’s)
Clinical efficacy demonstrated in more than 30 published clinical trials